{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T05:32:30Z","timestamp":1793079150660,"version":"4.5.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006546","name":"Angelini Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006546","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.yebeh.2026.111293","type":"journal-article","created":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:55:52Z","timestamp":1790488552000},"page":"111293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Socioeconomic disparities and regional variation in access to newer anti-seizure medications: a nationwide Swedish cohort study"],"prefix":"10.1016","volume":"185","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1954-540X","authenticated-orcid":false,"given":"Kristofer","family":"\u00c5hlin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Arpeg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1080-4307","authenticated-orcid":false,"given":"Kristoffer","family":"Illerg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia Morberg","family":"Lundgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Nicklasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Soeria-Atmadja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Adel\u00f6w","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2026.111293_b0005","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1528-1167.2010.02522.x","article-title":"Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005\u20132009","volume":"51","author":"Berg","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111293_b0010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1212\/WNL.0b013e318204a36a","article-title":"Estimating risk for developing epilepsy: a population-based study in Rochester","volume":"76","author":"Hesdorffer","year":"2011","journal-title":"Minnesota Neurology"},{"key":"10.1016\/j.yebeh.2026.111293_b0015","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/j.0013-9580.2004.17504.x","article-title":"The epidemiology of the comorbidity of epilepsy in the general population","volume":"45","author":"Gaitatzis","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111293_b0020","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1528-1157.1997.tb01194.x","article-title":"Cause\u2010specific mortality in epilepsy: a cohort study of more than 9,000 patients once hospitalized for epilepsy","volume":"38","author":"Nilsson","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111293_b0025","unstructured":"Overview | Epilepsies in children, young people and adults | Guidance | NICE 2022. https:\/\/www.nice.org.uk\/guidance\/ng217 (accessed August 26, 2026)."},{"key":"10.1016\/j.yebeh.2026.111293_b0030","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2026.111293_b0035","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1212\/WNL.0000000000005756","volume":"91","author":"Kanner","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2026.111293_b0040","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111293_b0045","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1111\/epi.18576","article-title":"Treatment of epilepsy using newer antiseizure medications: a retrospective cohort study of prescription patterns in Sweden 2013\u20132022","volume":"66","author":"Bolin","year":"2025","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111293_b0050","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1212\/cont.0000000000001540","article-title":"Implementing guidelines and measures in epilepsy care","volume":"31","author":"Baca","year":"2025","journal-title":"Continuum"},{"key":"10.1016\/j.yebeh.2026.111293_b0055","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1136\/bmj.325.7371.1013","article-title":"Socioeconomic variation in incidence of epilepsy: prospective community based study in south east England","volume":"325","author":"Heaney","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.yebeh.2026.111293_b0060","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1528-1167.2009.02481.x","article-title":"Estimation of the burden of active and life\u2010time epilepsy: a meta\u2010analytic approach","volume":"51","author":"Ngugi","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111293_b0065","doi-asserted-by":"crossref","unstructured":"Andersson K, Ozanne A, Edelvik Tranberg A, E Chaplin J, Bolin K, Malmgren K, et al. Socioeconomic outcome and access to care in adults with epilepsy in Sweden: A nationwide cohort study. Seizure 2020;74:71\u20136. doi: 10.1016\/j.seizure.2019.12.001.","DOI":"10.1016\/j.seizure.2019.12.001"},{"key":"10.1016\/j.yebeh.2026.111293_b0070","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1111\/epi.17728","article-title":"Health equity integrated epilepsy care and research: a narrative review","volume":"64","author":"Gotlieb","year":"2023","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111293_b0075","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1111\/epi.13201","article-title":"Epilepsy priorities in Europe: a report of the ILAE \u2010 IBE Epilepsy Advocacy Europe Task Force","volume":"56","author":"Baulac","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111293_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107050","article-title":"Poverty, insurance, and region as predictors of epilepsy treatment among US adults","volume":"107","author":"Szaflarski","year":"2020","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111293_b0085","doi-asserted-by":"crossref","DOI":"10.1212\/CPJ.0000000000200101","article-title":"Racial and ethnic differences in antiseizure medications among people with epilepsy on medicaid: a case of potential inequities","volume":"13","author":"Bensken","year":"2023","journal-title":"Neurol Clin Pract"},{"key":"10.1016\/j.yebeh.2026.111293_b0090","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1177\/15357597241258514","article-title":"Teratogenesis, perinatal, and neurodevelopmental outcomes after in utero exposure to antiseizure medication","volume":"26","author":"Pack","year":"2026","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.yebeh.2026.111293_b0095","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/jamaneurol.2017.3949","article-title":"Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort study","volume":"75","author":"Chen","year":"2018","journal-title":"JAMA Neurol"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505026004142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505026004142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T04:41:22Z","timestamp":1793076082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505026004142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":19,"alternative-id":["S1525505026004142"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2026.111293","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Socioeconomic disparities and regional variation in access to newer anti-seizure medications: a nationwide Swedish cohort study","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2026.111293","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111293"}}